Risk factors for graft loss in patients with recurrent IgA nephropathy after renal transplantation

Transplantation Proceedings

Volumn 36, Issue 5, 2004, Pages 1314-1316

  Namba, Y ^a   Oka, K ^a   Moriyama, T ^a   Ichimaru, N ^a   Kyo, M ^a   Kokado, Y ^a   Ito, T ^a   Imai, E ^a   Aozasa, K ^a   Okuyama, A ^a   Takahara, S ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HLA TYPING; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; RECIPIENT; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; SYSTOLIC HYPERTENSION;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOPSY; FEMALE; GLOMERULONEPHRITIS, IGA; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY TRANSPLANTATION; MALE; RECURRENCE; RENAL DIALYSIS; SURVIVAL ANALYSIS; TREATMENT FAILURE;

EID: 3142638657     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.05.044     Document Type: Article

References (8)

1. Ohmacht C., Kliem V., Burg M., et al. Recurrent immunoglobulin A nephropathy after renal transplantation a significant contributor to graft loss. Transplantation. 64:1997;1493-1496
2. Lee G., Glassock R.J. Treatment of Primary Glomerulonephritis. 1997;186 Oxford Medical Publications, Oxford
3. Ponticelli C., Traversi L., Feliciani A., et al. Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int. 60:2001;1948
4. Kyo M., Hatori M., Takahara S., et al. Morphological findings in non-episode biopsies of kidney transplant allografts treated with FK506 or cyclosporine. Transplant Int. 11:(suppl 1):1998;S100
5. Djamali A., Premasathian N., Pirsch J.D. Outcomes in kidney transplantation. Semin Nephrol. 23:2003;306
6. Freese P., Svalander C., Norden G., et al. Clinical risk factors for recurrence of IgA nephropathy. Clin Transplant. 13:1999;313
7. Brensilver J.M., Mallat S., Scholes J., et al. Recurrent IgA nephropathy in living related donor transplantation recurrence or transmission of familial disease? Am J Kidney Dis. 12:1988;147
8. Oka K., Imai E., Moriyama T., et al. A clinicopathological study of IgA nephropathy in renal transplant recipients beneficial effect of angiotensin-converting enzyme inhibitor. Nephrol Dial Transplant. 15:2000;689